ALDH2 and liver disorder: Our study provided a novel explanation for the sensitization of HBV-infected patients to alcohol-induced liver disease and it should be worth determining whether targeting the HBx–ALDH2 interaction can be a promising pharmacological therapeutic strategy for ALD with HBV infection.